1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand in Topical Analgesics
4.2.2 Growth in the Geriatric Population Resulting in a Rise in the Prevalence of Various Diseases
4.2.3 Cost Efficiency of OTC Analgesics Drugs
4.3 Market Restraints
4.3.1 Drug Tolerance, Dependence, And Addiction & Abuse?
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type of Drug
5.1.1 Acetaminophen
5.1.2 Nonsteroidal Anti-inflammatory Drug (NSAIDs)
5.1.3 Salicylates
5.1.4 Topical Analgesics
5.2 By Distribution Channel
5.2.1 Hospital Pharmacies
5.2.2 Retail Pharmacies
5.2.3 Online Pharmacies
5.2.4 Others Distribution Channels
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Johnson & Johnson
6.1.3 GlaxoSmithKline PLC
6.1.4 Mylan NV
6.1.5 Pfizer Inc.
6.1.6 Reckitt Benckiser Group PLC
6.1.7 Sanofi
6.1.8 Sun Pharmaceutical Industries Ltd
6.1.9 Takeda Pharmaceutical Company Limited

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned
 - Bayer AG
- Johnson & Johnson
- GlaxoSmithKline PLC
- Mylan NV
- Pfizer Inc.
- Reckitt Benckiser Group PLC
- Sanofi
- Sun Pharmaceutical Industries Ltd
- Takeda Pharmaceutical Company Limited